Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Research article

Aesthetic principles access thyroidectomy produces the best cosmetic outcomes as assessed using the patient and observer scar assessment scale

Authors: Xiao Ma, Qi-jun Xia, Guojun Li, Tian-xiao Wang, Qin Li

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

Thyroid carcinoma (TC) is more likely to occur in young women. The aim of this study was to compare the aesthetic effect of different thyroidectomies.

Methods

One hundred twenty female patients who underwent thyroidectomy were evenly distributed into three groups: conventional access (CA), aesthetic principles access (APA) and minimally invasive access (MIA). The Patient and Observer Scar Assessment Scale (POSAS) was used as the assessment tool for the linear scar.

Results

The patients in the MIA group showed significantly less intraoperative blood loss, less drainage, a shorter scar length and a shorter duration of drainage than those in the CA group and the APA group. However, the operation time of 129.0 min in the MIA group was significantly longer than the 79.6 min in the CA group and the 77.0 min in the APA group. The best aesthetic score, as assessed by the Observer Scar Assessment Scale (OSAS), was obtained in the APA group. The Patient Scar Assessment Scale (PSAS) scores were significantly lower in the APA group and CA group than in the MIA group. Significantly lower objective scar ratings were found in the APA group than in the other two groups.

Conclusion

These results show that APA produced the best surgical outcomes in TC patients, indicating that conventional thyroidectomy can produce an ideal aesthetic result using the principles of aesthetic surgery. Thyroid surgery need not be performed through excessively short incisions for the sake of patient satisfaction with the scar’s appearance.

Trial registration

This clinical trial was retrospectively registered on ClinicalTrials.gov PRS on August 1st,2017 (NCT03239769).
Literature
1.
Ghossein R, Ganly I, Biagini A, Robenshtok E, Rivera M, Tuttle RM. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases. Thyroid. 2014;24:245–53.CrossRefPubMed
2.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMed
3.
Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol. 2009;20:1728–35.CrossRefPubMed
4.
Lang BH, Wong CK, Tsang JS, Wong KP, Wan KY. A systematic review and meta-analysis evaluating completeness and outcomes of robotic thyroidectomy. Laryngoscope. 2015;125:509–18.CrossRefPubMed
5.
Lee HY, You JY, Woo SU, Son GS, Lee JB, Bae JW, et al. Transoral periosteal thyroidectomy: cadaver to human. Surg Endosc. 2015;29:898–904.CrossRefPubMed
6.
Landry CS, Grubbs EG, Perrier ND. Bilateral robotic-assisted transaxillary surgery. Arch Surg. 2010;145:717–20.CrossRefPubMed
7.
Cai Q, Huang XM, Sun W, Zheng YQ, Liang FY, Han P, et al. Gasless video-assisted bilateral thyroidectomy by the anterior chest wall approach : 4 years of experience. Surg Laparosc Endosc Percutan Tech. 2012;22:255–9.CrossRefPubMed
8.
Dralle H, Machens A, Thanh PN. Minimally invasive compared with concentional thyroidectomy for nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014;28:589–99.CrossRefPubMed
9.
Kim SM, Chun KW, Chang HJ, Kim BW, Lee YS, Chang HS, et al. Reducing neck incision length during thyroid surgery does not improve satisfaction in patients. Eur Arch Otorhinolaryngol. 2015;272:2433–8.CrossRefPubMed
10.
Dziegielewski PT, O’Connell DA, Rieger J, et al. The lip-splitting mandibulotomy: aesthetic and functional outcomes. Oral Oncol. 2010;46:612–7.CrossRefPubMed
11.
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2009;19:1167–214.CrossRef
12.
Chae JK, Kim JH, Kim EJ, Park K. Values of a patient and observer scar assessment scale to evaluate the facial skin graft scar. Ann Dermatol. 2016;28:615–23.CrossRefPubMedPubMedCentral
13.
Stavrou D, Haik J, Weissman O, Goldan O, Tessone A, Winkler E. Patient and observer scar assessment scale: how good is it? J Wound Care. 2009;18:171–6.CrossRefPubMed
14.
Wickham JE, Kellett MJ, Miller RA. Elective percutaneous nephrolithotomy in 50 patients: an analysis of the technique, results and complications. J Urol. 1983;129:904–6.CrossRefPubMed
15.
Miccoli P, Berti P, Raffaelli M, Materazzi G, Baldacci S, Rossi G. Comparison between minimally invasive video-assisted thyroidectomy and conventional thyroidectomy: a prospective randomized study. Surgery. 2001;130:1039–43.CrossRefPubMed
16.
Bellantone R, Lombardi CP, Bossola M, Boscherini M, De Crea C, Alesina PF, et al. Video-assisted vs conventional thyroid lobectomy: a randomized control trial. Arch Surg. 2002;137:301–4.CrossRefPubMed
17.
O’Connell DA, Diamond C, Seikaly H, Harris JR. Objective and subjective scar aesthetics in minimal access vs conventional access parathyroidectomy and thyroidectomy surgical procedures: a paired cohort study. Arch Otolaryngol Head Neck Surg. 2008;134:85–93.CrossRefPubMed
18.
Toll EC, Loizou P, Davis CR, Porter GC, Pothier DD. Scars and satisfaction: do smaller scars improve patient-reported outcome? Eur Arch Otorhinolaryngol. 2012;269:309–13.CrossRefPubMed
19.
Janis JE, Harrison B. Wound healing: part I. Basic science. Plast Reconstr Surg. 2014;133:199e–207e.CrossRefPubMed
20.
Slepavicius A, Beisa V, Janusonis V, Strupas K. Focused versus conventional parathyroidectomy for primary hyperparathyroidism: a prospective, randomized, blinded trial. Langenbeck's Arch Surg. 2008;393:659–66.CrossRef
21.
Mow CS, Woolson ST, Ngarmukos SG, Park EH, Lorenz HP. Comparison of scars from total hip replacements done with a standard or a mini-incision. Clin Orthop Relat Res. 2005;441:80–5.CrossRefPubMed
22.
Lang BH, Chan DT, Chow FC. Visualizing fewer parathyroid glands may be associated with lower hypoparathyroidism following total thyroidectomy. Langenbeck's Arch Surg. 2016;401:231–8.CrossRef
23.
Bliss RD, Gauger PG, Delbridge LW. Surgeon’s approach to the thyroid gland: surgical anatomy and the importance of technique. World J Surg. 2000;24:891–7.CrossRefPubMed
24.
Daher R, Lifante JC, Voirin N, Peix JL, Colin C, Kraimps JL, et al. Is it possible to limit the risks of thyroid surgery? Ann Endocrinol (Paris). 2015;76(1 Suppl 1):1S16–26.CrossRef
Metadata
Title
Aesthetic principles access thyroidectomy produces the best cosmetic outcomes as assessed using the patient and observer scar assessment scale
Authors
Xiao Ma
Qi-jun Xia
Guojun Li
Tian-xiao Wang
Qin Li
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3645-2

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue

Research article

A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice

Research article

Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study

Research article

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer

Research article

Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma

Study protocol

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

Research article

Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits